Search results for "Primary Prevention"

showing 10 items of 89 documents

Need for global action for cancer control.

2008

Malemedicine.medical_specialtyCancer ResearchInternational CooperationUterine cervix cancerDiseaseGlobal HealthWorld health03 medical and health sciences0302 clinical medicineCancer controlSDG 3 - Good Health and Well-beingNeoplasmsCancer screeningmedicineGlobal healthHumans030212 general & internal medicineGynecologyHealth Services Needs and DemandCancer preventionbusiness.industryHematologyPrimary Prevention/dk/atira/pure/subjectarea/asjc/2700/2730Risk analysis (engineering)Action (philosophy)Oncology030220 oncology & carcinogenesisFemalebusiness/dk/atira/pure/subjectarea/asjc/1300/1306Annals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Lipid Profile Results after Cardiovascular Prevention Programme: Euroaction Model in Spain

2020

Background: Cardiovascular prevention and rehabilitation programmes (CVPRP) are an established model of care designed to improve risk factor management. They have been successfully implemented in a variety of settings, in patients with coronary heart disease (CHD). Objective: To assess the long term impact of a nurse-coordinated, multidisciplinary, CVPRP in patients with CHD in the reduction of lipid profile and medication prescription in clinical practice. Methods: The study used an analytical, experimental, population based, prospective and longitudinal design. In Spain, the study was conducted in the Valencian Community, including two randomized hospitals. Coronary patients were prospec…

Malemedicine.medical_specialtyCardiotonic AgentsEndocrinology Diabetes and Metabolismmedicine.medical_treatmentNurse's RoleMedication prescriptionCardiovascular preventionIntervention (counseling)HumansImmunology and AllergyMedicineLongitudinal StudiesProspective StudiesMedical prescriptionHealth policyAgedRehabilitationmedicine.diagnostic_testbusiness.industryMiddle AgedLipidsCoronary heart diseaseEuropePrimary PreventionCardiovascular DiseasesSpainEmergency medicineFemaleDiet HealthyHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessLipid profileRisk Reduction BehaviorEndocrine, Metabolic & Immune Disorders - Drug Targets
researchProduct

Epidemiology, prevention and screening for prostate cancer.

1996

Prostate cancer is a growing social problem. The economical impact is high and is likely to become greater in future years, not only because the number of patients diagnosed with prostatic neoplasias is increasing steadily, but also because of the promotion of screening programmes and the rise in the number of surgical procedures available. It can be concluded that, at the present stage, widespread implementation of screening cannot be recommended. The answer to the question of screening can only be provided by large randomised trials, comparing either screening versus no screening, or early versus delayed treatment in patients in whom early cancer is detected by screening.

Malemedicine.medical_specialtyEarly cancerUrologyCost-Benefit AnalysisRisk AssessmentProstate cancerEpidemiologymedicineHumansMass ScreeningIn patientStage (cooking)Intensive care medicineRandomized Controlled Trials as TopicPalpationbusiness.industryRectumProstatic NeoplasmsDelayed treatmentSurgical proceduresMiddle AgedProstate-Specific Antigenmedicine.diseasePrimary PreventionPhysical therapybusinessEuropean urology
researchProduct

Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence.

2014

BACKGROUND AND OBJECTIVES:: It is well established by a large number of randomized controlled trials that lowering blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) by drugs are powerful means to reduce stroke incidence, but the optimal BP and LDL-C levels to be achieved are largely uncertain. Concerning BP targets, two hypotheses are being confronted: first, the lower the BP, the better the treatment outcome, and second, the hypothesis that too low BP values are accompanied by a lower benefit and even higher risk. It is also unknown whether BP lowering and LDL-C lowering have additive beneficial effects for the primary and secondary prevention of stroke, and whether these…

Malemedicine.medical_specialtyPhysiologyHypercholesterolemiaLow density lipoprotein cholesterolBlood Pressurelaw.inventionCognitionRandomized controlled triallawRecurrenceInternal medicineblood pressure cognitive decline low-density lipoprotein cholesterol primary prevention secondary prevention strokeInternal MedicineSecondary PreventionMedicineHumansCognitive declineStrokeBeneficial effectsRandomized Controlled Trials as TopicSecondary preventionbusiness.industryMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARECholesterol LDLmedicine.diseasePrimary PreventionStrokeBlood pressureCholesterolCardiologyPhysical therapylipids (amino acids peptides and proteins)Cardiology and Cardiovascular MedicinebusinessStroke incidenceCognition Disordersblood pressure; cognitive decline; low-density lipoprotein cholesterol; primary prevention; secondary prevention; strokeJournal of hypertension
researchProduct

Intervención de ergonomía participativa en una empresa del sector químico

2012

ResumenSe describe una intervención de ergonomía participativa iniciada en abril de 2010 en una empresa del sector químico de la Comunidad Valenciana. Se presentó el programa de intervención en la empresa, se acordó el ámbito de la intervención (dos líneas, 24 trabajadores y trabajadoras) y se constituyó un grupo de trabajo (Grupo Ergo, formado por personas responsables, técnicos y delegados de prevención de la empresa) encargado de guiar la intervención. Se recogió mediante cuestionario información acerca de daños y riesgos ergonómicos en los trabajadores y trabajadoras de los puestos seleccionados. Esta información fue analizada por el Grupo Ergo y discutida posteriormente en círculos de …

Medical educationTrastornos musculoesqueléticosPrimary preventionOccupational healthParticipationPublic Health Environmental and Occupational HealthDirect participationHuman factors and ergonomicsSalud laboralChemical companyParticipatory ergonomicsIntervention levelMusculoskeletal disordersParticipaciónIntervention (counseling)ErgonomicsErgonomíaPrevención primariaPsychologyGaceta Sanitaria
researchProduct

Theory-based digital intervention to promote weight loss and weight loss maintenance (Choosing Health)

2020

IntroductionDigital behavioural weight loss interventions have the potential to improve public health; however, these interventions are often not adequately tailored to the needs of the participants. This is the protocol for a trial that aims to determine the effectiveness and cost-effectiveness of the Choosing Health programme as a means to promote weight loss and weight loss maintenance among overweight/obese adults.Methods and analysisThe proposed study is a two-group randomised controlled trial with a nested interrupted time series (ITS) within-person design. Participants (n=285) will be randomly assigned to either the Choosing Health digital intervention or a control group. For interve…

N of 1 trialComparative Effectiveness ResearchPsychological interventionOverweightCardiovascularOral and gastrointestinalDISEASElaw.inventionBEHAVIORAL INTERVENTIONSRandomized controlled trialWeight losslaw1506teleterveydenhuoltoRandomized Controlled Trials as TopicNutrition and MetabolismElectronic Mailpublic healthRPRIMARY-CAREGeneral MedicineinterventiotutkimusStrokeN-OF-1OBESITYPublic Health and Health ServicesMedicinemedicine.symptom1714Adultmedicine.medical_specialtyClinical Trials and Supportive ActivitiesClinical Sciencespreventive medicinepainonhallintaDIETQuality of life (healthcare)Clinical ResearchWeight LossmedicineHumansObesityMetabolic and endocrinePreventive healthcareNutritionnutrition & dieteticsOther Medical and Health SciencesOVERWEIGHTbusiness.industryPublic healthPreventionlaihdutusADULTSOverweightPHYSICAL-ACTIVITYCost Effectiveness ResearchterveyskäyttäytyminenPhysical therapyQuality of Life3.1 Primary prevention interventions to modify behaviours or promote wellbeingPolandGeneric health relevancebusinessBMJ Open
researchProduct

Plasma lipidome patterns associated with cardiovascular risk in the PREDIMED trial: A case-cohort study.

2017

Abstract Background The study of the plasma lipidome may help to better characterize molecular mechanisms underlying cardiovascular disease. The identification of new lipid biomarkers could provide future targets for prevention and innovative therapeutic approaches. In the frame of the PREDIMED trial, our aim was to examine the associations of baseline lipidome patterns or their changes with the risk of clinical CVD events. Methods We included 983 participants in our case-cohort study. The end-point was the incidence of major CVD during 4.8years of median follow-up. We repeatedly measured 202 plasma known lipid metabolites at baseline and after 1-year of intervention. Principal component an…

OncologyMalemedicine.medical_specialtyMediterranean dietCase-cohort030209 endocrinology & metabolismDisease030204 cardiovascular system & hematologyDiet MediterraneanArticleCohort Studies03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRisk FactorsInternal medicineMediterranean dietLipidomicsMedicineHumansNutsOlive OilAgedPrimary preventionbusiness.industryCholesterolIncidence (epidemiology)Case-control studyLipidomeMiddle AgedCardiovascular diseaseLipidschemistryCardiovascular DiseasesCase-Control StudiesLipidomicsPhosphatidylcholinesFemaleCholesterol EstersCardiology and Cardiovascular MedicinebusinessBiomarkersCohort studyFollow-Up Studies
researchProduct

Statins and new-onset diabetes

2013

Statins are highly efficacious lipid modifying agents that reduce the risk for cardiovascular (CV) events in both primary and secondary prevention settings. However, statins affect molecular mechanisms which adversely impact on insulin sensitivity and β-cell function, thereby increasing risk for new onset diabetes mellitus (NOD). Defining the mechanisms involved is the focus of considerable current investigation. The statins reduce the risk for CV events in normoglycemic patients as well as in those with diabetes mellitus (DM) and their benefits outweigh the risk of inducing NOD. We review the clinical evidence for NOD with statin treatment, as well as the potential mechanisms involved. Our…

PharmacologySecondary preventionLIPID MODIFYING AGENTSbusiness.industrynutritional and metabolic diseasesInsulin sensitivityNodPharmacologyStatin treatmentBioinformaticsmedicine.diseaseRisk AssessmentPrimary PreventionDiabetes Mellitus Type 2New onset diabetesCardiovascular DiseasesDiabetes mellitusDrug DiscoverySecondary PreventionmedicineHumansHydroxymethylglutaryl-CoA Reductase InhibitorsRisk assessmentbusinessnew-onset diabetes mellitus statin cardiovascular events insulin sensitivity primary prevention secondary prevention
researchProduct

Strategies for Disease Prevention and Health Promotion in Urban Areas: The Erice 50 Charter

2017

The Erice 50 Charter titled "Strategies for Diseases Prevention and Health Promotion in Urban Areas" was unanimously approved at the conclusion of the 50th Residential Course "Urban Health. Instruments for promoting health and for assessing hygienic and sanitary conditions in urban areas", held from 29th March to 2nd April 2017 in Erice, at the "Ettore Majorana" Foundation and Centre for Scientific Culture and promoted by the International School of Epidemiology and Preventive Medicine "G. D'Alessandro" and the Study Group "Building Hygiene" of the Italian Society of Hygiene, Preventive Medicine and Public Health (SItI). At the conclusion of the intense learning experience during the Course…

Planning and Designing StrategiesUrban HealthHealth PromotionUrban Health Public Health Built Environment Planning and Designing Strategies Health PromotionPrimary PreventionItalyPlanning and Designing Strategiebuilt environment; health promotion; planning and designing strategies; public health; urban health; public health environmental and occupational health; infectious diseasesHumansUrban Health; Public Health; Built Environment; Planning and Designing Strategies; Health promotionHealth promotionPublic HealthBuilt EnvironmentBuilt Environment; Health Promotion; Planning and Designing Strategies; Public Health; Urban Health; Health Promotion; Humans; Italy; Primary Prevention; Urban Health
researchProduct

Childhood trauma and substance use underlying psychosis: a systematic review

2020

[EN] Background: Schizophrenia spectrum disorders (SSD) are mental diseases caused by a combination of genetic susceptibility and a number of environmental factors. Among these factors, the role of traumatic events suffered in childhood, as well as that of substance use, have been of particular research interest. Objectives: To conduct a systematic review to clarify whether there is an interaction between childhood trauma and substance use related to the diagnosis or symptoms of SSD. It was also the objective of this review to collate the associations that may exist between the three variables of the study (trauma, substance use and psychosis). Methods: We conducted a systematic search resu…

PsychosisSubstances useRC435-571Poison controlEsquizofreniaReview Article药物滥用Cannabis useSuicide preventionOccupational safety and healthChildhood traumaConsumo de cannabis思觉失调Injury preventionmedicinePsicosisPsychiatryWindow of opportunitybusiness.industryHuman factors and ergonomicsConsumo de sustanciasmedicine.diseasePsychosis• Schizophrenia is caused by a combination of genetic susceptibility and a number of environmental factors. Traumatic events suffered in childhood as well as substance use have been of particular interest.• Our results reveal a positive association between traumatic experiences in childhood and drug use and their interaction with schizophrenia spectrum disorders.• Detecting cases of childhood trauma as well as cases of trauma associated with substance use could be useful for the primary prevention of some psychiatric diseases such as psychosis.大麻使用精神分裂症SchizophreniaTrauma infantilSchizophreniabusiness童年创伤Clinical psychology
researchProduct